Phase II Clinical Trial of SHR-1139 Injection in Patients With Psoriasis
Clinical trial NCT07719530 · RECRUITING
Trial details
- NCT number
- NCT07719530
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-04
- Primary completion
- 2026-12-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.